These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 31096002

  • 21. The Rising Tide of Antibiotic Resistance: A Study on Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae.
    Ejaz H, Qamar MU, Farhana A, Younas S, Batool A, Lone D, Atif M, Alruways MW, Alruwaili M, Hamad I, Selim S, Mazhari BBZ, Farooq A, Junaid K.
    J Clin Lab Anal; 2024 May; 38(10):e25081. PubMed ID: 38884333
    [Abstract] [Full Text] [Related]

  • 22. Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 (blaNDM-1) in Bandar Abbas, South of Iran.
    Shoja S, Ansari M, Faridi F, Azad M, Davoodian P, Javadpour S, Farahani A, Mobarrez BD, Karmostaji A.
    Microb Drug Resist; 2018 May; 24(4):447-454. PubMed ID: 28972857
    [Abstract] [Full Text] [Related]

  • 23. Contribution of acrB upregulation & OmpC/Ompk36 loss over the presence of blaNDM towards carbapenem resistance development among pathogenic Escherichia coli & Klebsiella spp.
    Pal A, Dhara L, Tripathi A.
    Indian J Med Res; 2019 Apr; 149(4):528-538. PubMed ID: 31411177
    [Abstract] [Full Text] [Related]

  • 24. Dual-tubed multiplex-PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp.
    Kazi M, Nikam C, Shetty A, Rodrigues C.
    J Appl Microbiol; 2015 May; 118(5):1096-102. PubMed ID: 25647446
    [Abstract] [Full Text] [Related]

  • 25. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
    Kazmierczak KM, Tsuji M, Wise MG, Hackel M, Yamano Y, Echols R, Sahm DF.
    Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986
    [Abstract] [Full Text] [Related]

  • 26. Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018.
    Huang YS, Tsai WC, Li JJ, Chen PY, Wang JT, Chen YT, Chen FJ, Lauderdale TL, Chang SC.
    Sci Rep; 2021 Jan 28; 11(1):2609. PubMed ID: 33510280
    [Abstract] [Full Text] [Related]

  • 27. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH, Kim GR, Jeong J, Kim S, Shin JH.
    Jpn J Infect Dis; 2020 Nov 24; 73(6):431-436. PubMed ID: 32475870
    [Abstract] [Full Text] [Related]

  • 28. The predominance of Klebsiella pneumoniae carbapenemase (KPC-type) gene among high-level carbapenem-resistant Klebsiella pneumoniae isolates in Baghdad, Iraq.
    Hussein NH, Mohammed Kareem S, Hussein Al-Kakei SN, Taha BM.
    Mol Biol Rep; 2022 Jun 24; 49(6):4653-4658. PubMed ID: 35471622
    [Abstract] [Full Text] [Related]

  • 29. Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
    Bedenić B, Sardelić S, Bogdanić M, Zarfel G, Beader N, Šuto S, Krilanović M, Vraneš J.
    Arch Microbiol; 2021 May 24; 203(4):1825-1831. PubMed ID: 33507339
    [Abstract] [Full Text] [Related]

  • 30. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Wang Q, Wang X, Wang J, Ouyang P, Jin C, Wang R, Zhang Y, Jin L, Chen H, Wang Z, Zhang F, Cao B, Xie L, Liao K, Gu B, Yang C, Liu Z, Ma X, Jin L, Zhang X, Man S, Li W, Pei F, Xu X, Jin Y, Ji P, Wang H.
    Clin Infect Dis; 2018 Nov 13; 67(suppl_2):S196-S205. PubMed ID: 30423057
    [Abstract] [Full Text] [Related]

  • 31. Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
    Zarfel G, Hoenigl M, Würstl B, Leitner E, Salzer HJ, Valentin T, Posch J, Krause R, Grisold AJ.
    Clin Microbiol Infect; 2011 Nov 13; 17(11):E5-8. PubMed ID: 21939472
    [Abstract] [Full Text] [Related]

  • 32. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J, Študentová V, Jakubů V, Adámková V, Dvořáková L, Balejova M, Bergerová T, Chmelařová E, Ježek P, Kabelíková P, Kolář M, Paterová P, Tejkalová R, Papagiannitsis C, Žemličková H.
    Epidemiol Mikrobiol Imunol; 2015 Jun 13; 64(2):87-91. PubMed ID: 26099612
    [Abstract] [Full Text] [Related]

  • 33. Emergence of Multidrug-Resistant New Delhi Metallo-β-Lactamase-1-Producing Klebsiella pneumoniae in Egypt.
    Khalil MAF, Elgaml A, El-Mowafy M.
    Microb Drug Resist; 2017 Jun 13; 23(4):480-487. PubMed ID: 27575913
    [Abstract] [Full Text] [Related]

  • 34. Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.
    Barnes MD, Taracila MA, Good CE, Bajaksouzian S, Rojas LJ, van Duin D, Kreiswirth BN, Jacobs MR, Haldimann A, Papp-Wallace KM, Bonomo RA.
    Antimicrob Agents Chemother; 2019 Aug 13; 63(8):. PubMed ID: 31182530
    [Abstract] [Full Text] [Related]

  • 35. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
    Huang SR, Liu MF, Lin CF, Shi ZY.
    J Microbiol Immunol Infect; 2014 Jun 13; 47(3):187-96. PubMed ID: 23200553
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of phenotypic tests for detection of Klebsiella pneumoniae carbapenemase and metallo-beta-lactamase in clinical isolates of Escherichia coli and Klebsiella species.
    Chauhan K, Pandey A, Asthana AK, Madan M.
    Indian J Pathol Microbiol; 2015 Jun 13; 58(1):31-5. PubMed ID: 25673588
    [Abstract] [Full Text] [Related]

  • 37. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M, Kato H, Sugano T, Okade H, Sato N, Shibata Y, Sakanashi D, Asai N, Koizumi Y, Suematsu H, Yamagishi Y, Mikamo H.
    Int J Antimicrob Agents; 2021 May 13; 57(5):106330. PubMed ID: 33789129
    [Abstract] [Full Text] [Related]

  • 38. The emergence of blaOXA-48 and blaNDM among ESBL-producing Klebsiella pneumoniae in clinical isolates of a tertiary hospital in Iran.
    Moghadampour M, Rezaei A, Faghri J.
    Acta Microbiol Immunol Hung; 2018 Aug 01; 65(3):335-344. PubMed ID: 30024268
    [Abstract] [Full Text] [Related]

  • 39. Sequence Type 273 Carbapenem-Resistant Klebsiella pneumoniae Carrying blaNDM-1 and blaIMP-4.
    Liu L, Feng Y, Long H, McNally A, Zong Z.
    Antimicrob Agents Chemother; 2018 Jun 01; 62(6):. PubMed ID: 29610206
    [Abstract] [Full Text] [Related]

  • 40. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates.
    Shortridge D, Kantro V, Castanheira M.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0450722. PubMed ID: 36622238
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 50.